pegloticase
Selected indexed studies
- Pegloticase. (, 2006) [PMID:34406723]
- Pegloticase Therapy and G6PD Genotype. (, 2012) [PMID:33001605]
- Pegloticase. (, 2012) [PMID:31644077]
_Worker-drafted node — pending editorial review._
Connections
pegloticase is a side effect of
Sources
- Pegloticase. (2006) pubmed
- Pegloticase Therapy and G6PD Genotype. (2012) pubmed
- Pegloticase. (2012) pubmed
- Pegloticase treatment of chronic refractory gout: Update on efficacy and safety. (2020) pubmed
- Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. (2011) pubmed
- A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings. (2023) pubmed
- The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout. (2024) pubmed
- Pegloticase. (2026) pubmed
- Pegloticase for chronic gout. (2010) pubmed
- Pegloticase-Associated Hemolysis. (2019) pubmed